Bruker Corporation
54.43USD
-3.9400 (-6.75%)
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $0.42▼ | $0.55 | 0 | 11 |
| Next quarter | $0.9▲ | $0.87 | 11 | 0 |
| Current year | $2.12▲ | $2.12 | 5 | 5 |
| Next year | $2.41▼ | $2.41 | 3 | 8 |
Beat in 3 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $0.38 | $0.49 | +0.11 (+27.5%) |
| 2026-03-31 | $0.23 | $0.31 | +0.08 (+34.8%) |
| 2025-12-31 | $0.65 | $0.59 | -0.06 (-9.8%) |
| 2025-09-30 | $0.32 | $0.45 | +0.13 (+38.8%) |
188 ratings from 30 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| Citigroup | Maintained | Neutral | $60 $53 | Aug 5, 2026 |
| Citigroup | Maintained | Neutral | $44 $60 | Jul 8, 2026 |
| Leerink Partners | Maintained | Outperform | $60 $70 | Jul 7, 2026 |
| Guggenheim | Maintained | Buy | $50 $70 | Jun 29, 2026 |
| Barclays | Maintained | Overweight | $53 $60 | Jun 24, 2026 |
| JP Morgan | Maintained | Overweight | $55 $65 | Jun 8, 2026 |
| UBS | Maintained | Neutral | $40 $45 | May 7, 2026 |
| Citigroup | Maintained | Neutral | $40 $44 | May 7, 2026 |
| TD Cowen | Maintained | Hold | $43 $45 | May 7, 2026 |
| Barclays | Maintained | Overweight | $45 $53 | May 7, 2026 |
| Barclays | Maintained | Overweight | $50 $45 | Apr 15, 2026 |
| Barclays | Maintained | Overweight | $50 $45 | Apr 14, 2026 |
| Guggenheim | Maintained | Buy | $58 $50 | Mar 30, 2026 |
| Citigroup | Maintained | Neutral | $53 $40 | Feb 13, 2026 |
| Goldman Sachs | Maintained | Sell | $40 $35 | Feb 13, 2026 |
| TD Cowen | Maintained | Hold | $53 $43 | Feb 13, 2026 |
| Barclays | Maintained | Overweight | $55 $50 | Feb 13, 2026 |
| Guggenheim | Maintained | Buy | $53 $58 | Jan 26, 2026 |
| Citigroup | Maintained | Neutral | $40 $53 | Jan 16, 2026 |
| TD Cowen | Maintained | Hold | $42 $53 | Jan 7, 2026 |
| Guggenheim | Maintained | Buy | $45 $53 | Jan 5, 2026 |
| Barclays | Maintained | Overweight | $45 $55 | Dec 15, 2025 |
| JP Morgan | Maintained | Overweight | $50 $55 | Dec 15, 2025 |
| Wells Fargo | Maintained | Overweight | $48 $55 | Dec 15, 2025 |
| B of A Securities | Maintained | Buy | $43 $60 | Dec 15, 2025 |
67 filings from 18 insiders · 14 buy / 7 sell over 6m
Officers and directors of BRKR, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| MUNCH MARK ROBERTOfficer | Exercise | 2.0k | $22.19 | $44k | Aug 14, 2026 |
| MUNCH MARK ROBERTOfficer | Sell | 2.0k | $57.60 | $115k | Aug 14, 2026 |
| BURES THOMASOfficer | Grant | 4.0k | — | — | Aug 14, 2026 |
| MUNCH MARK ROBERTOfficer | Grant | 14.4k | — | — | Aug 14, 2026 |
| PRAUSE BURKHARDOfficer | Grant | 3.3k | — | — | Aug 14, 2026 |
| SREGA JUERGENOfficer | Grant | 16.9k | — | — | Aug 14, 2026 |
| LAUKIEN FRANK HChief Executive Officer | Grant | 29.5k | — | — | Aug 14, 2026 |
| HERMAN GERALD NChief Financial Officer | Grant | 15.8k | — | — | Aug 14, 2026 |
| MUNCH MARK ROBERTOfficer | Exercise | 2.0k | $22.19 | $44k | Jul 15, 2026 |
| MUNCH MARK ROBERTOfficer | Sell | 2.0k | $60.25 | $121k | Jul 15, 2026 |
| MUNCH MARK ROBERTOfficer | Exercise | 2.0k | $22.19 | $44k | Jun 15, 2026 |
| MUNCH MARK ROBERTOfficer | Sell | 2.0k | $54.76 | $110k | Jun 15, 2026 |
| MUNCH MARK ROBERTOfficer | Exercise | 2.0k | $22.19 | $44k | May 15, 2026 |
| MUNCH MARK ROBERTOfficer | Sell | 2.0k | $43.90 | $88k | May 15, 2026 |
| BERNARD THIERRYDirector | Grant | 2.9k | — | — | May 15, 2026 |
| MUNCH MARK ROBERTOfficer | Exercise | 2.0k | $22.19 | $44k | Apr 15, 2026 |
| MUNCH MARK ROBERTOfficer | Sell | 2.0k | $39.90 | $80k | Apr 15, 2026 |
| MUNCH MARK ROBERTOfficer | Exercise | 2.0k | $22.19 | $44k | Mar 13, 2026 |
| MUNCH MARK ROBERTOfficer | Sell | 2.0k | $35.44 | $71k | Mar 13, 2026 |
| MUNCH MARK ROBERTOfficer | Exercise | 2.0k | $22.19 | $44k | Feb 13, 2026 |
No analyst notes on BRKR yet.
Analyst Ratings
12 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 2 | 6 | 4 | 1 | 0 | Buy2.31 |
| 1 mo ago | 2 | 6 | 4 | 1 | 0 | Buy2.31 |
| 2 mo ago | 2 | 6 | 4 | 1 | 0 | Buy2.31 |
| 3 mo ago | 2 | 6 | 4 | 1 | 0 | Buy2.31 |